Early Predictors of In-Hospital Mortality and Cardiac Dysfunction in Patients with ST-Segment Elevation Myocardial
Corina Cinezan1,2, Alexandra Manuela Buzle1,2,3, Camelia Bianca Rus1,2,3
1Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
Insights
Predictors of mortality in ST-segment elevation myocardial infarction (STEMI) include left ventricular dysfunction, anemia, and renal impairment. Early identification of these factors improves risk stratification for STEMI patients.
Area of Science:
- Cardiology
- Internal Medicine
- Critical Care Medicine
Background:
- ST-segment elevation myocardial infarction (STEMI) continues to pose significant health risks despite advancements in treatment.
- Effective risk stratification is crucial for managing STEMI patients and improving outcomes.
- Identifying early predictors of adverse events in STEMI is essential.
Purpose of the Study:
- To identify independent predictors of in-hospital mortality in patients with STEMI.
- To assess the association of left ventricular ejection fraction (LVEF) and ischemic mitral regurgitation (IMR) with adverse outcomes.
- To evaluate the role of clinical, laboratory, and echocardiographic variables in predicting mortality.
Main Methods:
- Retrospective analysis of 512 STEMI patients undergoing revascularization within 6 hours of symptom onset.
- Multivariable logistic regression used to identify independent predictors of in-hospital mortality.
- Echocardiographic and laboratory data, including hemoglobin and glomerular filtration rate, were analyzed.
Main Results:
- In-hospital mortality was observed in 9.4% of patients.
- Reduced LVEF (<40%), moderate-to-severe IMR, lower hemoglobin, and reduced glomerular filtration rate were independent predictors of mortality.
- The predictive model demonstrated good discrimination with an AUC of 0.88.
Conclusions:
- Left ventricular dysfunction, IMR, anemia, and renal impairment are significant predictors of in-hospital mortality in STEMI.
- Integrating echocardiographic and laboratory data can enhance early risk stratification for STEMI patients.
- These findings can guide clinical decision-making and improve patient management.
Abstract:
Background: Despite advances in reperfusion therapy, ST-segment elevation myocardial infarction (STEMI) remains associated with substantial morbidity and mortality. Early identification of predictors of adverse outcomes is essential for improving risk stratification. Methods: This retrospective study included 512 STEMI patients who underwent coronary revascularization within 6 h of symptom onset. Clinical, laboratory, angiographic and echocardiographic variables were analyzed. The primary endpoint was in-hospital mortality. Secondary outcomes included reduced left ventricular ejection fraction (LVEF < 40%) and moderate-to-severe ischemic mitral regurgitation (IMR). Independent predictors of in-hospital mortality were identified using multivariable logistic regression, while secondary outcomes were described to characterize the study population. Model performance was evaluated using ROC analysis. Results: In-hospital mortality occurred in 9.4% of patients. Reduced LVEF was present in 26.2%, and IMR in 10.9%. Independent predictors of mortality included LVEF < 40% (OR 5.72, 95% CI 2.77-11.80, p < 0.001), IMR (OR 2.61, 95% CI 1.14-5.97, p = 0.023), lower hemoglobin levels (OR 0.74, 95% CI 0.61-0.91, p = 0.003), and reduced glomerular filtration rate (OR 0.96, 95% CI 0.95-0.98, p < 0.001). The model demonstrated good discrimination (AUC 0.88). Complete revascularization was not independently associated with mortality. Conclusions: Left ventricular dysfunction, IMR, anemia, and renal impairment are strong predictors of in-hospital mortality in STEMI patients. Integrating echocardiographic and laboratory parameters may improve early risk stratification and guide clinical decision-making.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care

